Published in Cancer Biol Ther on June 25, 2010
The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells. Cancer Biol Ther (2011) 1.01
The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer. Front Oncol (2014) 0.92
Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer. Gynecol Oncol (2012) 0.88
Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells. Mol Carcinog (2011) 0.86
Aspirin Blocks EGF-stimulated Cell Viability in a COX-1 Dependent Manner in Ovarian Cancer Cells. J Cancer (2013) 0.81
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer. Oncotarget (2015) 0.77
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul (1984) 35.22
Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov (2006) 14.01
Cancer of the ovary. N Engl J Med (2004) 11.21
The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet (2009) 9.68
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A (1993) 4.82
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther (2006) 4.09
Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol (2008) 3.68
Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell (2003) 2.54
Histone deacetylase inhibitors: signalling towards p21cip1/waf1. Int J Biochem Cell Biol (2007) 2.20
Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Cancer Lett (2009) 1.99
Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res (2003) 1.53
A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2008) 1.42
Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy. Cancer Biol Ther (2007) 1.40
Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res (2005) 1.36
Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Res (2006) 1.22
Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas. Neoplasia (2008) 1.19
Ovarian cancer. Surg Clin North Am (2008) 1.16
Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem (2006) 1.14
Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2010) 1.13
Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res (2007) 1.00
Dietary aspirin decreases the stage of ovarian cancer in the hen. Gynecol Oncol (2008) 0.92
Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity. Mini Rev Med Chem (2007) 0.87
Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death. Surgery (2004) 0.86
Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells. Oncol Rep (2008) 0.84
Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer. Gynecol Oncol (2004) 0.78
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. Cancer Res (2008) 3.98
An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell (2013) 2.30
Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell (2010) 2.20
Telephone triage in Western Australia. Med J Aust (2002) 2.06
Inhibition of α-helix-mediated protein-protein interactions using designed molecules. Nat Chem (2013) 2.02
Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis. Gastroenterology (2005) 1.93
Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res (2003) 1.91
Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy. Cancer Biol Ther (2007) 1.40
Bovine TB and badger culling. Vet Rec (2012) 1.39
Knowledge translation for effective consumers. Phys Ther (2007) 1.37
Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors. Cancer Res (2005) 1.26
Oligobenzamide proteomimetic inhibitors of the p53-hDM2 protein-protein interaction. Chem Commun (Camb) (2009) 1.24
Evaluation of NHMRC funded research completed in 1992, 1997 and 2003: gains in knowledge, health and wealth. Med J Aust (2006) 1.21
Pattern recognition of proteins based on an array of functionalized porphyrins. J Am Chem Soc (2006) 1.18
EPHB4 and survival of colorectal cancer patients. Cancer Res (2006) 1.17
Population-attributable risk estimates for risk factors associated with Campylobacter infection, australia. Emerg Infect Dis (2008) 1.16
Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment. Clin Cancer Res (2010) 1.12
Keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells. Cancer Biol Ther (2007) 1.09
Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunit. Eur J Biochem (2002) 1.07
N-alkylated oligoamide alpha-helical proteomimetics. Org Biomol Chem (2010) 1.06
The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. Cancer Res (2009) 1.04
Proteomic changes during intestinal cell maturation in vivo. J Proteomics (2008) 1.02
Pattern-based detection of different proteins using an array of fluorescent protein surface receptors. J Am Chem Soc (2004) 1.01
The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells. Cancer Biol Ther (2011) 1.01
Gene expression profile of trisomy 21 placentas: a potential approach for designing noninvasive techniques of prenatal diagnosis. Am J Obstet Gynecol (2002) 1.01
Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res (2007) 1.00
Clients' perspective on service quality for type 2 diabetes in Australia. Aust N Z J Public Health (2007) 0.96
Synthesis of functionalised aromatic oligamide rods. Org Biomol Chem (2007) 0.95
Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma. PLoS One (2013) 0.93
Selective and potent proteomimetic inhibitors of intracellular protein-protein interactions. Angew Chem Int Ed Engl (2015) 0.92
Development of the effective musculoskeletal consumer scale. J Rheumatol (2007) 0.91
The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium. Mod Pathol (2013) 0.91
Helix-mediated protein--protein interactions as targets for intervention using foldamers. Amino Acids (2011) 0.91
Sensitivity of Raman spectroscopy to normal patient variability. J Biomed Opt (2011) 0.91
Customer quality in health care. Patient Educ Couns (2008) 0.91
Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys (2003) 0.91
Attributes and skills of an effective musculoskeletal consumer. J Rheumatol (2005) 0.91
Selective protein-surface sensing using ruthenium(II) tris(bipyridine) complexes. Chemistry (2010) 0.90
Small-molecule proteomimetic inhibitors of the HIF-1α-p300 protein-protein interaction. Chembiochem (2014) 0.89
Customer quality and type 2 diabetes from the patients' perspective: a cross-sectional study. J Res Health Sci (2010) 0.89
Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases. Am J Cancer Res (2013) 0.89
Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy. J Ovarian Res (2012) 0.88
Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer. Gynecol Oncol (2012) 0.88
TR3 modulates platinum resistance in ovarian cancer. Cancer Res (2013) 0.88
Targeted approaches for reducing inequities in chronic disease. Med J Aust (2003) 0.88
Nuclear translocation of calcineurin Abeta but not calcineurin Aalpha by platelet-derived growth factor in rat aortic smooth muscle. Am J Physiol Cell Physiol (2007) 0.87
Ovarian volume measurements in mice with high-resolution ultrasonography. J Ultrasound Med (2007) 0.86
Macrocyclic scaffolds derived from p-aminobenzoic acid. Chem Commun (Camb) (2007) 0.86
2-O-alkylated para-benzamide α-helix mimetics: the role of scaffold curvature. Org Biomol Chem (2012) 0.86
Microwave assisted solid phase synthesis of highly functionalized N-alkylated oligobenzamide α-helix mimetics. Bioorg Med Chem (2012) 0.85
A case of extrauterine endometrial stromal sarcoma in the colon diagnosed three decades after hysterectomy for benign disease. Case Rep Obstet Gynecol (2013) 0.85
Protein surface recognition using geometrically pure Ru(II) tris(bipyridine) derivatives. Chem Commun (Camb) (2010) 0.85
Environment-gene interactions in intestinal cancer. Eur J Cancer Prev (2002) 0.84
Substituent control over dimerization affinity of triply hydrogen bonded heterodimers. Org Lett (2010) 0.84
Mechanisms of disease pathogenesis in long QT syndrome type 5. Am J Physiol Cell Physiol (2009) 0.84
An orthotopic model of platinum-sensitive high grade serous fallopian tube carcinoma. Int J Clin Exp Pathol (2011) 0.84
Orthogonal functionalisation of α-helix mimetics. Org Biomol Chem (2014) 0.84
Photo-induced covalent cross-linking for the analysis of biomolecular interactions. Chem Soc Rev (2013) 0.84
Solid-phase methodology for synthesis of O-alkylated aromatic oligoamide inhibitors of α-helix-mediated protein-protein interactions. Chemistry (2013) 0.84
Telephone-based psychiatry advice service for general practitioners. Med J Aust (2005) 0.83
Trifluoromethyldiazirine: an effective photo-induced cross-linking probe for exploring amyloid formation. Chem Commun (Camb) (2008) 0.83
Catalytic unfolding and proteolysis of cytochrome C induced by synthetic binding agents. J Am Chem Soc (2004) 0.83
Modeling of arylamide helix mimetics in the p53 peptide binding site of hDM2 suggests parallel and anti-parallel conformations are both stable. PLoS One (2012) 0.83
Differential vimentin expression in ovarian and uterine corpus endometrioid adenocarcinomas: diagnostic utility in distinguishing double primaries from metastatic tumors. Int J Gynecol Pathol (2014) 0.82
Near-infrared Raman Microspectroscopy Detects High-risk Human Papillomaviruses. Transl Oncol (2012) 0.82
Design, synthesis and binding studies of a novel quadruple ADDA hydrogen-bond array. Org Biomol Chem (2012) 0.82
Aspirin Blocks EGF-stimulated Cell Viability in a COX-1 Dependent Manner in Ovarian Cancer Cells. J Cancer (2013) 0.81
Conformer-independent ureidoimidazole motifs--tools to probe conformational and tautomeric effects on the molecular recognition of triply hydrogen-bonded heterodimers. Chemistry (2011) 0.81
Responsiveness of the Effective Consumer Scale (EC-17). J Rheumatol (2009) 0.81
Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance. Hum Pathol (2013) 0.81
Monosubstituted alkenyl amino acids for peptide "stapling". Chem Commun (Camb) (2013) 0.80
Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies. Mol Biosyst (2015) 0.80
Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model. J Ovarian Res (2013) 0.80
Coenzyme Q10 and lipid-related gene induction in HeLa cells. Am J Obstet Gynecol (2004) 0.80
Pleomorphic liposarcoma of the uterine corpus with focal smooth muscle differentiation. Int J Gynecol Pathol (2011) 0.80
Intestinal epithelial-specific PTEN inactivation results in tumor formation. Am J Physiol Gastrointest Liver Physiol (2011) 0.79
The mechanism of formation of amide-based interlocked compounds: prediction of a new rotaxane-forming motif. Chemistry (2004) 0.79
Analysis of amyloid nanostructures using photo-cross-linking: in situ comparison of three widely used photo-cross-linkers. ACS Chem Biol (2014) 0.79
Patient perspectives on consistency of medical care with recommended care in type 2 diabetes. Diabetes Care (2007) 0.78
Adrenal gland metastasis is an unusual manifestation of endometrial cancer. Case Rep Surg (2013) 0.77
Covalent cross-linking within supramolecular peptide structures. Anal Chem (2012) 0.77
Ditopic triply hydrogen-bonded heterodimers. Org Biomol Chem (2011) 0.77
Conformer independent heterodimerisation of linear arrays using three hydrogen bonds. Chem Commun (Camb) (2008) 0.77
Multivalent helix mimetics for PPI-inhibition. Org Biomol Chem (2015) 0.77
Hydrogen bonding: Attractive arrays. Nat Chem (2011) 0.77
Cellular uptake of highly-functionalized ruthenium(II) tris-bipyridine protein-surface mimetics. Bioorg Med Chem Lett (2011) 0.77
Bovine TB and wildlife control. Vet Rec (2011) 0.75
Religious slaughter in context. Vet Rec (2012) 0.75
Coordinate patterns of estrogen receptor, progesterone receptor, and Wilms tumor 1 expression in the histopathologic distinction of ovarian from endometrial serous adenocarcinomas. Ann Diagn Pathol (2013) 0.75
The use of electrospray mass spectrometry to determine speciation in a dynamic combinatorial library for anion recognition. Chemistry (2012) 0.75
Evidence into practice: the mental health hurdle is high. Med J Aust (2006) 0.75
"Magic rod" rotaxanes: the hydrogen bond-directed synthesis of molecular shuttles under thermodynamic control. Org Lett (2003) 0.75
Salpingo-oophorectomy specimens for endometrial cancer staging: a comparative analysis of representative sampling versus whole tissue processing. Hum Pathol (2012) 0.75
NHS Direct audited. Telephone triage in Western Australia is cheaper than NHS Direct. BMJ (2002) 0.75
Chemical sensing: Nanonose for sniffing out proteins. Nat Chem (2009) 0.75